The Anti-Tumor Activator sMEK1 and Paclitaxel Additively Decrease Expression of HIF-1α And VEGF via mTORC1-S6K/4E-BP-dependent Signaling Pathways

Oncotarget - United States
doi 10.18632/oncotarget.2119
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

Tanshinone IIA Inhibits HIF-1α and VEGF Expression in Breast Cancer Cells via mTOR/p70S6K/RPS6/4E-BP1 Signaling Pathway

PLoS ONE
Multidisciplinary
2015English

Targeting Stat3 Blocks Both HIF-1 and VEGF Expression Induced by Multiple Oncogenic Growth Signaling Pathways

Oncogene
Cancer ResearchGeneticsMolecular Biology
2005English

UVB Induces HIF-1α-Dependent TSLP Expression via the JNK and ERK Pathways

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2013English

Pyruvate Promotes Tumor Angiogenesis Through HIF-1-dependent PAI-1 Expression

International Journal of Oncology
Cancer ResearchOncology
2011English

The mTORC1 Effectors S6K1 and 4e-Bp Play Different Roles in CNS Axon Regeneration

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2014English

Tetrandrine Suppresses Lung Cancer Growth and Induces Apoptosis, Potentially via the VEGF/HIF-1α/ICAM-1 Signaling Pathway

Oncology Letters
Cancer ResearchOncology
2018English

Tissue Expression of Hypoxia-Inducible Factor 1 Alpha (HIF-1A) in Wilms Tumor

Journal of Dr Behcet Uz Children s Hospital
2019English

Correlation Between Liver Cancer Pain and the HIF-1 and VEGF Expression Levels

Oncology Letters
Cancer ResearchOncology
2016English

The mTORC1/4E-BP/eIF4E Axis Promotes Antibody Class Switching in B Lymphocytes

Journal of Immunology
AllergyImmunology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy